DRI Healthcare Trust's recent earnings report shows a significant miss in EPS estimates, raising concerns about its growth trajectory.
On August 7, 2026, DRI Healthcare Trust (DHT-UN.TO) announced its financial results for the quarter ending June 30, 2026. The company reported earnings per share (EPS) of $0.56, which was below the estimated $0.60, resulting in a surprise of -6.67%. This is a crucial moment for investors as the company navigates a competitive healthcare landscape.
Recent earnings trend
Advertisement
DRI Healthcare Trust
DHT-UN.TO
DHT-UN.TO
DRI Healthcare Trust
WealthAwesomeAdvertisement
Market cap
$991.95M
Div. yield
2.40%
Div. / share
$0.41
52W high
$19.75
52W low
$13.41
1W change
+1.85%
Beta
0.67
Analyst Price Targets
Based on analyst covering DHT-UN
Wall Street analysts forecast DHT-UN stock price to rise 28.2% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$22.60
+28.2% Upside
Current Price
C$17.63
Last close
Analyst ratings and price targets are updated periodically. Not financial advice.
Advertisement
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on DHT-UN's historical volatility
30-Day Vol
31.2%
Annualized
90-Day Vol
27.5%
Annualized
Trend (90d)
+43.9%
Annualized drift
90d Mean
C$20.62
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$18.58 | C$16.68 – C$20.68 |
| 60 trading days | C$19.57 | C$16.81 – C$22.79 |
| 90 trading days | C$20.62 | C$17.12 – C$24.84 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Analyst coverage: 4 analyst(s) cover this name; upcoming EPS consensus is available.
Beat estimates in 2 of the last 4 comparable quarter(s).
| Fiscal period | Report date | Actual EPS | Estimate | Surprise |
|---|---|---|---|---|
| 2026-06-30 | 2026-08-07 | 0.5600 | 0.6000 | -6.7% |
| 2026-03-31 | 2026-05-14 | 0.6800 | 0.5500 | +23.6% |
| 2025-12-31 | 2026-03-03 | 0.7800 | 0.5200 | +50.0% |
| 2025-09-30 | 2025-11-05 | 0.5500 | 0.5500 | +0.0% |
| 2025-06-30 | 2025-08-13 | 0.5100 | 0.4800 | +6.3% |
| 2025-03-31 | 2025-05-12 | 0.4300 | 0.5100 | -15.7% |
Advertisement
Investor takeaway: Despite the earnings miss, DRI Healthcare Trust has demonstrated resilience in its operational performance. Analysts remain optimistic, suggesting potential upside. Investors should keep an eye on both the current earnings trend and the company's strategic moves in the healthcare market moving forward.
EPS Misses by 6.67%, Revenue Growth Remains on Track
With an EPS of $0.56 compared to an estimate of $0.60, DRI Healthcare Trust's performance highlights possible volatility in earnings expectations. However, revenue growth is still strong, projected at 7.7% for the upcoming quarter.
Bull case
Analysts are optimistic about DRI Healthcare Trust, with an average price target of CAD 22.60, indicating a potential upside of 28.2% from the last close. The company has a history of growth, having beaten estimates in two of the last four quarters. Continued revenue growth and strategic acquisitions could support future earnings.
Bear case
The recent earnings miss raises concerns about the trust's ability to sustain its growth trajectory, especially as the pharmaceutical sector faces increased scrutiny and competition. The profit margin is currently negative at -25.19%, and the trust's TTM EPS is also in the red, signaling ongoing challenges that might affect investor confidence.
Advertisement
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
